Physician profile
Joseph P Burns
NPI 1457347874
$375,601.96
in general payments reported to CMS, 2019-2025
21 companies · $49K in 2025
The $49K reported for 2025 was more than what 95% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,199 · 2020: $1,564 · 2021: $4,190 · 2022: $176K · 2023: $67K · 2024: $70K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $111K · Consulting Fee: $65K · Travel and Lodging: $6,107 · Food and Beverage: $3,067 · Gift: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $111,248.26 |
| Consulting Fee | $65,045.00 |
| Travel and Lodging | $6,107.36 |
| Food and Beverage | $3,067.14 |
| Gift | $160.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $283,216.28 | 2019-2025 | Biobrace 23mm |
| Biorez, INC. | $60,430.18 | 2022 | |
| Medical Device Business Services, INC. | $16,003.98 | 2023-2025 | Fms Duo, N/A, Fms |
| Arthrex, INC. | $6,321.06 | 2019-2024 | |
| Depuy Synthes Sales INC. | $2,155.59 | 2019-2025 | Vapr, Fms, Dynacord |
| Depuy Synthes Products, INC. | $2,070.00 | 2021 | |
| Stryker Corporation | $1,793.72 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Micromed INC | $1,301.00 | 2019 | |
| United Orthopedics LLC | $679.95 | 2020 | |
| Zimmer Biomet Holdings, INC. | $662.65 | 2020-2025 | |
| Team 1, LLC | $581.20 | 2024 | |
| Smith+Nephew, INC. | $136.21 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Kerecis Limited | $59.65 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Dynasplint Systems INC. | $51.90 | 2022 | |
| Acumed LLC | $29.52 | 2024 | Acumed |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $28.64 | 2022 | |
| Anika Therapeutics, INC. | $24.62 | 2024 | Ovomotion |
| Ferring Pharmaceuticals INC. | $16.30 | 2019 | |
| Heron Therapeutics, INC. | $14.85 | 2024 | Zynrelef |
| Spr Therapeutics, INC | $13.64 | 2024 | Sprint Pns System |
| Vericel Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.